Septerna, Inc. — Investor Relations & Filings
Filings indexed
117
across all filing types
Latest filing
2026-04-30
Annual Report
Country
US
United States of America
Listing
US
SEPN
Septerna, Inc. is a clinical-stage biotechnology company that discovers and develops novel oral small molecule medicines targeting G protein-coupled receptors (GPCRs). The company leverages its proprietary Native Complex Platform™ to isolate and analyze GPCRs in their natural state, which facilitates the development of new therapies. Septerna is advancing a wholly-owned pipeline with an initial focus on endocrinology, immunology, inflammation, and metabolic diseases. One of its clinical programs involves SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator being evaluated for the treatment of mast cell-driven diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Septerna, Inc. (0001984086) (Filer) | 2026-04-30 | English | |
| 8-K - Septerna, Inc. (0001984086) (Filer) | 2026-04-13 | English | |
| 4 - SEPTERNA, INC. (0001984086) (Filer) | 2026-03-04 | English | |
| 8-K - SEPTERNA, INC. (0001984086) (Filer) | 2026-03-02 | English | |
| 4 - SEPTERNA, INC. (0001984086) (Filer) | 2026-02-20 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 39218242 | ARS - Septerna, Inc. (0001984086) (Filer) | 2026-04-30 | English | ||
| 34413066 | 8-K - Septerna, Inc. (0001984086) (Filer) | 2026-04-13 | English | ||
| 32900856 | 4 - SEPTERNA, INC. (0001984086) (Filer) | 2026-03-04 | English | ||
| 32900858 | 8-K - SEPTERNA, INC. (0001984086) (Filer) | 2026-03-02 | English | ||
| 32900857 | 4 - SEPTERNA, INC. (0001984086) (Filer) | 2026-02-20 | English | ||
| 32277327 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 32277400 | 4 Filing | 2026-02-10 | English | ||
| 32277353 | 4 Filing | 2026-02-10 | English | ||
| 32277321 | 4 Filing | 2026-02-10 | English | ||
| 32277319 | 4 Filing | 2026-02-10 | English | ||
| 32277318 | 4 Filing | 2026-02-10 | English | ||
| 32277317 | 4 Filing | 2026-02-10 | English | ||
| 32277312 | 4 Filing | 2026-02-10 | English | ||
| 32277307 | 4 Filing | 2026-02-10 | English | ||
| 13664402 | 3 | 2026-01-15 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
APURES CO., LTD.
Biotech firm providing MICROPIG models, bio-resources, and …
|
149300 | KR | Professional, scientific and te… |
|
Aran Research & Development (1982) Ltd.
A product design and development firm providing services fr…
|
ARAN | IL | Professional, scientific and te… |
|
Arch Biopartners Inc.
Developing novel drugs for acute kidney injury (AKI) and ch…
|
ARCH | CA | Professional, scientific and te… |
|
ARCHER MATERIALS LIMITED
Develops semiconductor devices for quantum computing and me…
|
AXE | AU | Professional, scientific and te… |
|
ARGENICA THERAPEUTICS LIMITED
Clinical-stage developer of neuroprotective drugs for acute…
|
AGN | AU | Professional, scientific and te… |
|
ARIUS Research Inc.
Discovery and development of targeted antibody therapeutics…
|
ARI | CA | Professional, scientific and te… |
|
AROVELLA THERAPEUTICS LIMITED
Develops off-the-shelf iNKT cell therapies for blood cancer…
|
ALA | AU | Professional, scientific and te… |
|
Artiva Biotherapeutics, Inc.
Develops allogeneic, off-the-shelf NK cell therapies for ca…
|
ARTV | US | Professional, scientific and te… |
|
ARVINAS, INC.
Clinical-stage biopharma developing therapeutics based on t…
|
ARVN | US | Professional, scientific and te… |
|
Asarina Pharma AB
A biotechnology company in liquidation, formerly focused on…
|
ASAP | SE | Professional, scientific and te… |
Septerna, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32396/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32396 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32396 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32396 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32396}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Septerna, Inc. (id: 32396)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.